B. Woodhams

发表

Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease.

O. Olivieri, N. Martinelli, M. Pinotti, 2020, Thrombosis research.

Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation

P. Simioni, L. Spiezia, E. Campello, 2017, Clinical chemistry and laboratory medicine.

Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

A. Hamsten, A. Silveira, U. de Faire, 2012, Thrombosis research.

Factor VIIa-antithrombin complexes in children with ischemic stroke.

P. Simioni, S. Gavasso, L. Spiezia, 2011, Thrombosis research.

Factor VIIa‐Antithrombin complexes during cardiac surgery using cardiopulmonary bypass

S. Davidson, B. Woodhams, 2011, International journal of laboratory hematology.

Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis

P. Simioni, D. Tormene, S. Gavasso, 2010, Thrombosis and Haemostasis.

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

M. Maier‐Redelsperger, R. Girot, F. Lionnet, 2012, Thrombosis and Haemostasis.

Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery

F. Biancari, P. Simioni, S. Gavasso, 2016, Internal and Emergency Medicine.

Microparticle association and heterogeneity of tumor‐derived tissue factor in plasma: is it important for coagulation activation?

I. Sargent, V. Bogdanov, L. Robles-Carrillo, 2014, Journal of thrombosis and haemostasis : JTH.

The evaluation of two automated soluble fibrin assays for use in the routine hospital laboratory

J. Antovic, B. Woodhams, E. Westerlund, 2013, International journal of laboratory hematology.

Circulating microparticles in carriers of prothrombin G20210A mutation

P. Simioni, S. Gavasso, L. Spiezia, 2014, Thrombosis and Haemostasis.

An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies

P. D. de Groot, S. Čučnik, B. Božič, 2011, Journal of thrombosis and haemostasis : JTH.

Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis.

P. Simioni, S. Gavasso, L. Spiezia, 2012, Thrombosis research.

Annexin A5 polymorphism (−1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome

P. D. de Groot, R. Derksen, W. V. van Heerde, 2006, Annals of the rheumatic diseases.

Procoagulant Phospholipids and Tissue Factor Activity in Cerebrospinal Fluid from Patients with Intracerebral Haemorrhage

M. Vasse, J. Dreyfus, P. van Dreden, 2014, Advances in hematology.

Factor VIIa‐antithrombin complexes in patients with non‐neoplastic portal vein thrombosis with and without cirrhosis

P. Simioni, M. Senzolo, S. Gavasso, 2013, International journal of laboratory hematology.

Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?

P. Simioni, M. Senzolo, S. Gavasso, 2014, Internal and Emergency Medicine.

Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.

A. D’Angelo, N. Caron, P. Della Valle, 2002, Blood.

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

J. Rak, N. Mackman, H. Versteeg, 2016, Oncotarget.

von Willebrand Factor Activity Detected in a Monoclonal Antibody-based ELISA: an Alternative to the Ristocetin Cofactor Platelet Agglutination Assay for Diagnostic Use

A. Goodall, K. Pasi, B. Woodhams, 1997, Thrombosis and Haemostasis.

VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia

A. Hamsten, A. Silveira, O. McLeod, 2018, International journal of laboratory hematology.

Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia.

P. Simioni, Sonila Dhima, D. Tormene, 2015, Thrombosis research.

Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.

P. Simioni, D. Tormene, G. Tognin, 2006, Thrombosis research.

Rapid radioimmunoassay for fibrinopeptide a in human plasma

B. Woodhams, P. Kernoff, 1981 .

Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S

P. Simioni, D. Tormene, S. Gavasso, 2015, Thrombosis and Haemostasis.

Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis

P. Prandoni, P. Simioni, D. Tormene, 2012, Thrombosis and Haemostasis.

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis

N. Semeraro, M. Colucci, F. Scaraggi, 2013, Journal of thrombosis and haemostasis : JTH.

Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism.

P. Simioni, S. Gavasso, C. Bulato, 2013, Thrombosis and haemostasis.

Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women

P. Simioni, Sonila Dhima, E. Cosmi, 2015, Scandinavian journal of clinical and laboratory investigation.

Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: the cause of hypercoagulability?

R. Favier, P. van Dreden, A. Rousseau, 2012, Thrombosis research.

Toward standardization of assays measuring extracellular vesicle‐associated tissue factor activity

R. Nieuwland, N. Mackman, F. Dignat-George, 2019, Journal of thrombosis and haemostasis : JTH.

Phospholipid‐dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

A. Falanga, L. Russo, A. Rambaldi, 2014, American journal of hematology.

Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity

P. Simioni, S. Gavasso, L. Spiezia, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

M. Bruzelius, E. Svenungsson, G. Grosso, 2017, Thrombosis research.

Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia

P. Simioni, E. Cosmi, S. Visentin, 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Stability of coagulation proteins in frozen plasma

B. Woodhams, Y. Gourmelin, M. J. Blanco, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion.

R. Shaw, B. Woodhams, P. Kernoff, 1989, Thrombosis research.

Problems with antisera specificity in immunoassays for human fibrinopeptide A.

B. Woodhams, P. Kernoff, 1986, Thrombosis research.

Decreased procoagulant phospholipids in patients treated by vitamin K antagonists.

M. Vasse, B. Lenormand, A. Rousseau, 2012, Thrombosis research.

On‐demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients

M. Holmström, J. Antovic, I. Elezović, 2012, International journal of laboratory hematology.

Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital—Meaning of the ISTH score system, fibrin monomers, and lipoprotein–C‐reactive protein complex formation

K. Boudjeltia, C. Cauchie, P. Cauchie, 2006, American journal of hematology.

Interference of trasylol with immunological assays for protein C.

B. Woodhams, 1987, Thrombosis Research.

Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure

M. Vasse, J. Dreyfus, A. Rousseau, 2012, Clinical chemistry and laboratory medicine.

Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids

A. Rousseau, B. Woodhams, T. Exner, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The simultaneous measurement of total and free protein S by ELISA.

B. Woodhams, 1988, Thrombosis research.

The application of polyethylene glycol to radioimmunoassays used in haemostasis.

B. Woodhams, P. Kernoff, 1983, Thrombosis research.

Differences between the venoms of two sub-species of Russell's viper: Vipera russelli pulchella and Vipera russelli siamensis.

R. Hutton, S. E. Wilson, B. Woodhams, 1990, Toxicon : official journal of the International Society on Toxinology.

Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype

C. Lindsell, Syed A. Ahmad, V. Bogdanov, 2015, Annals of Surgical Oncology.

The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo

R. Hutton, B. Woodhams, T. Than, 1989, British journal of haematology.

Rapid Radioimmunoassay For Fibrinopeptide A In Human Plasma

B. Woodhams, P. Kernoff, 1981, Thrombosis and Haemostasis.

K. Boudjeltia, C. Cauchie, P. Cauchie, 2006, American journal of hematology.

Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk

Justo Aznar, R. Bertina, F. España, 2004, Thrombosis and Haemostasis.

The specificity of antisera raised by oestradiol-17β-3-hemisuccinyl-bovine serum albumin

D. Exley, B. Woodhams, 1976, Steroids.

Apolipoprotein C-III Strongly Correlates with Activated Factor VII–Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation

D. Girelli, O. Olivieri, N. Martinelli, 2019, Thrombosis and Haemostasis.

Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism.

P. Simioni, S. Gavasso, L. Spiezia, 2013, Thrombosis research.

Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events

R. Vettor, P. Simioni, S. Gavasso, 2014, Thrombosis and Haemostasis.

Activated factor VII–antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study

D. Girelli, O. Olivieri, N. Martinelli, 2016, Journal of thrombosis and haemostasis : JTH.

SAT0004 Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor - TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome

E. Svenungsson, B. Woodhams, M. Adam, 2014 .

C0467: Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor – TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome

E. Svenungsson, A. Antovic, B. Woodhams, 2014 .

Prevalence of antiphospholipid antibodies in psychiatric patients users and non‐users of antipsychotics

M. Walter, D. Mottier, A. Delluc, 2014, British journal of haematology.

Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication

S. Lynch, B. Festoff, B. Woodhams, 2012, Journal of the Neurological Sciences.

Comparative studies of rabbit and human recombinant tissue factor reagents.

K. Denson, B. Woodhams, M. Haddon, 1999, Thrombosis research.

Haemostasis Change in Intensive Care Patients with Severe Sepsis and Patients with Organ Failure without Sepsis

M. Vasse, B. Lenormand, B. Woodhams, 2011 .

Effects of chemical modifiers on recombinant factor VIII activity.

C. O. Fágáin, B. Woodhams, F. Manning, 1995, Thrombosis research.

Detection of PF4-heparin Auto-antibodies by ELISA

B. Woodhams, M. Grimaux, 1999, Thrombosis and Haemostasis.